Five new treatments approved for blood cancer by the FDA

In the last six weeks the U.S. Food and Drug Administration (FDA) has approved five additional treatments for blood cancer.  The rate at which new treatments are being approved in the U.S. is incredibly encouraging.  It demonstrates the progress researchers are making in finding new and novel ways to treat cancer.  It is also frustrating … Continued

Partnering to provide more hope to blood cancer patients

Prof Miles Prince AM was devastated when back in 2018, his patient Tom Long had to embark on a journey to Seattle USA in order to receive chimeric antigen receptor T-cell (CAR T) therapy via a clinical trial.  He knew that while Australia had the clinical expertise to administer CAR T-cell therapy, we did not … Continued

New multiple myeloma treatment approved in the U.S.

In June 2019, the U.S. FDA approved selinexor (Xpovio) in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.  Myeloma patients had to have been treated with at least four prior therapies.  In November 2020, the results of the BOSTON study were published which demonstrated the benefits of using selinexor earlier in … Continued

Latest grants announced in Australia-US blood cancer research co-funding partnership

Two new research projects co-funded through a partnership between America’s The Leukemia & Lymphoma Society (LLS), Snowdome Foundation and Leukaemia Foundation will focus on acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS), seeking to improve understanding and treatment of these blood cancers. Prof. Ravindra Majeti, Stanford University in the US, will join with Assoc. Prof. … Continued

Professor John Pimanda – Expediting drug discovery in MDS

Professor Pimanda is incredibly curious. His observations around why cells behave in certain ways and respond variably to stimuli led him down a cell biology research path.  He was particularly drawn to blood stem cell development and maturation and the disruption of this orderly process in blood cancers. In 2008, when John was setting up … Continued

Clinical trials are saving blood cancer patients’ lives in Western Australia

On Thursday 12th November, Snowdome and Blood Cancer Research WA (BCRWA) held their annual Blood, Sweat and Tears of Joy educational event at the new EZONE, University of Western Australia. The event was hosted by Prof Chan Cheah who interviewed a panel of clinicians, researchers and courageous patients. The conversations uncovered the value of the … Continued

The importance of clinical trials for blood cancer patients

Dr Kat Lewis works as a Haematology Clinical Research Fellow for Blood Cancer Research WA.  Kat packed up her life and family in the UK two years ago to gain the opportunity to learn more about clinical research and the role clinical trials can play in the management of blood cancer.   Her days are filled … Continued

Prof Mark Dawson receives Frank Fenner Prize for Life Scientist of the Year

Professor Mark Dawson has been awarded the 2020 Frank Fenner Prize for Life Scientist of the Year.  This prestigious award is one of the Australian Prime Minister’s Prizes for Science which recognises the contributions our scientists, innovators and science teachers make to Australia’s scientific commercialisation capabilities. Professor Dawson is both a haematologist clinician as well … Continued